- Home
- CIEN vs EW Comparison
CIEN vs EW Comparison
Compare CIEN & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIEN | EW |
|---|---|---|
| Founded | 1992 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Industrial Specialties |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.7B | 50.2B |
| IPO Year | 1996 | 1999 |
Fundamental Metrics
Financial Performance| Metric | CIEN | EW |
|---|---|---|
| Price | $409.37 | $82.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 21 |
| Target Price | ★ $318.29 | $96.47 |
| AVG Volume (30 Days) | 2.8M | ★ 4.1M |
| Earning Date | 03-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.55 | N/A |
| EPS | 1.03 | ★ 1.83 |
| Revenue | $4,769,507,000.00 | ★ $6,067,600,000.00 |
| Revenue This Year | $27.20 | $13.39 |
| Revenue Next Year | $16.37 | $9.78 |
| P/E Ratio | $372.97 | ★ $45.10 |
| Revenue Growth | ★ 18.79 | 11.55 |
| 52 Week Low | $49.21 | $65.94 |
| 52 Week High | $419.80 | $87.89 |
Technical Indicators
Market Signals| Indicator | CIEN | EW |
|---|---|---|
| Relative Strength Index (RSI) | 67.21 | 47.70 |
| Support Level | $206.17 | $80.91 |
| Resistance Level | N/A | $82.64 |
| Average True Range (ATR) | 24.69 | 2.11 |
| MACD | 4.84 | -0.29 |
| Stochastic Oscillator | 91.40 | 31.38 |
Price Performance
Historical ComparisonAbout CIEN Ciena Corporation
Ciena is a telecommunications equipment provider focused on optical transport technologies, with clients in a number of industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises worldwide. The company provides equipment, software, and services that support transport, switching, aggregation, service delivery, and data traffic management.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.